Lithium Carbonate
NDC 67046-397
Product Information
Lithium Carbonate is a NDA-approved product labeled by Contract Pharmacy Services-pa. This medication is used to treat manic-depressive disorder (bipolar disorder). It is supplied as a white product. This product entry covers the primary NDC 67046-397 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
54;213
Code Structure Chart
Product Details
What is NDC 67046-397?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- LITHIUM CARBONATE (UNII: 2BMD2GNA4V)
- LITHIUM CATION (UNII: 8H8Z5UER66) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- TALC (UNII: 7SEV7J4R1U)
- GELATIN, UNSPECIFIED (UNII: 2G86QN327L)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- AMMONIA (UNII: 5138Q19F1X)
- ALCOHOL (UNII: 3K9958V90M)
- FERROSOFERRIC OXIDE (UNII: XM0M87F357)
- ISOPROPYL ALCOHOL (UNII: ND2M416302)
- BUTYL ALCOHOL (UNII: 8PJ61P6TS3)
- PROPYLENE GLYCOL (UNII: 6DC9Q167V3)
- SHELLAC (UNII: 46N107B71O)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 311355 - lithium carbonate 150 MG Oral Capsule
- RxCUI: 311355 - LiCO3 150 MG Oral Capsule
* Please review the full disclaimer at the bottom of this page.